Janus Henderson Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.6M | Buy |
2,873,053
+2,843,980
| +9,782% | +$20.4M | 0.01% | 562 |
|
|
2025
Q1 | $188K | Hold |
29,073
| – | – | ﹤0.01% | 2372 |
|
|
2024
Q4 | $227K | Buy |
29,073
+13,300
| +84% | +$104K | ﹤0.01% | 2378 |
|
|
2024
Q3 | $170K | Hold |
15,773
| – | – | ﹤0.01% | 2471 |
|
|
2024
Q2 | $133K | Sell |
15,773
-2,083,584
| -99% | -$17.5M | ﹤0.01% | 2475 |
|
|
2024
Q1 | $14.1M | Buy |
2,099,357
+2,083,065
| +12,786% | +$14M | 0.01% | 624 |
|
|
2023
Q4 | $95.9K | Sell |
16,292
-1,620,669
| -99% | -$9.54M | ﹤0.01% | 2527 |
|
|
2023
Q3 | $16M | Buy |
1,636,961
+318,849
| +24% | +$3.11M | 0.01% | 578 |
|
|
2023
Q2 | $15.6M | Sell |
1,318,112
-344,153
| -21% | -$4.08M | 0.01% | 599 |
|
|
2023
Q1 | $17.9M | Buy |
1,662,265
+60,068
| +4% | +$648K | 0.01% | 596 |
|
|
2022
Q4 | $18.5M | Sell |
1,602,197
-1,774,861
| -53% | -$20.5M | 0.01% | 584 |
|
|
2022
Q3 | $50.4M | Buy |
3,377,058
+1,246,562
| +59% | +$18.6M | 0.02% | 515 |
|
|
2022
Q2 | $19.2M | Sell |
2,130,496
-1,034,745
| -33% | -$9.33M | 0.01% | 572 |
|
|
2022
Q1 | $23.7M | Buy |
3,165,241
+649,987
| +26% | +$4.87M | 0.01% | 712 |
|
|
2021
Q4 | $21.6M | Buy |
2,515,254
+21,293
| +0.9% | +$183K | 0.01% | 770 |
|
|
2021
Q3 | $21M | Buy |
2,493,961
+55,760
| +2% | +$469K | 0.01% | 780 |
|
|
2021
Q2 | $19.8M | Buy |
2,438,201
+155,073
| +7% | +$1.26M | 0.01% | 786 |
|
|
2021
Q1 | $20M | Buy |
2,283,128
+554,458
| +32% | +$4.87M | 0.01% | 768 |
|
|
2020
Q4 | $19.4M | Buy |
1,728,670
+1,651,080
| +2,128% | +$18.5M | 0.01% | 756 |
|
|
2020
Q3 | $715K | Buy |
+77,590
| New | +$715K | ﹤0.01% | 1177 |
|